High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$468K
$468,310
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2026-03-02
$104,086x2
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-03-02 | $104,086x2 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2026-02-02
$124,147
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-02 | $124,147 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2025-12-01
$116,781
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-12-01 | $116,781 | S | Form 4 |
|
XERS
S
Xeris Biopharma Holdings, Inc.
Hecht Beth
• Officer • See Remarks
10b5-1 Sell
2025-11-11
$123,296
|
||||||
| XERS |
Xeris Biopharma Holdings, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-11 | $123,296 | S | Form 4 |